Literature DB >> 1396552

Primary and secondary structure of the pore-forming peptide of pathogenic Entamoeba histolytica.

M Leippe1, E Tannich, R Nickel, G van der Goot, F Pattus, R D Horstmann, H J Müller-Eberhard.   

Abstract

A pore-forming peptide is implicated in the potent cytolytic activity of pathogenic Entamoeba histolytica. Using NH2-terminal sequence information of this peptide, the corresponding cDNA was isolated. The cDNA-deduced amino acid sequence revealed a putative signal peptide and a mature peptide of 77 amino acids including six cysteine residues. Computer-aided secondary structure analysis predicted that the peptide would be composed of four adjacent alpha-helices, and CD spectroscopy indicated an all alpha-helical conformation. The tertiary structure appears to be stabilized by three disulfide bonds; the pore-forming activity was not sensitive to heat but was lost in the presence of reducing agents. Sequence homology was found to the saposins and to surfactant-associated protein B, both mammalian polypeptides of similar size and secondary structure but of non-lytic function. In particular, the six cysteine residues were found to be conserved, suggesting a common motif for stabilizing a favourable tertiary structure. Compared with previously characterized toxic peptides also containing three disulfide bonds, the amoeba peptide may represent a distinct class of biologically active peptides.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1396552      PMCID: PMC556807          DOI: 10.1002/j.1460-2075.1992.tb05432.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  46 in total

Review 1.  Amphipathic helix motif: classes and properties.

Authors:  J P Segrest; H De Loof; J G Dohlman; C G Brouillette; G M Anantharamaiah
Journal:  Proteins       Date:  1990

Review 2.  Saposin proteins: structure, function, and role in human lysosomal storage disorders.

Authors:  J S O'Brien; Y Kishimoto
Journal:  FASEB J       Date:  1991-03-01       Impact factor: 5.191

Review 3.  Colicins: prokaryotic killer-pores.

Authors:  F Pattus; D Massotte; H U Wilmsen; J Lakey; D Tsernoglou; A Tucker; M W Parker
Journal:  Experientia       Date:  1990-02-15

4.  The bacterial porin superfamily: sequence alignment and structure prediction.

Authors:  D Jeanteur; J H Lakey; F Pattus
Journal:  Mol Microbiol       Date:  1991-09       Impact factor: 3.501

Review 5.  Immunobiology of human infection by Entamoeba histolytica.

Authors:  J I Ravdin
Journal:  Pathol Immunopathol Res       Date:  1989

6.  Conformational forces affecting the folding pathways of dendrotoxins I and K from black mamba venom.

Authors:  M Hollecker; D Larcher
Journal:  Eur J Biochem       Date:  1989-01-15

7.  Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.

Authors:  R K Saiki; D H Gelfand; S Stoffel; S J Scharf; R Higuchi; G T Horn; K B Mullis; H A Erlich
Journal:  Science       Date:  1988-01-29       Impact factor: 47.728

Review 8.  Mechanism of lymphocyte-mediated cytotoxicity.

Authors:  P A Henkart
Journal:  Annu Rev Immunol       Date:  1985       Impact factor: 28.527

Review 9.  Molecular mechanisms of cytotoxicity mediated by Entamoeba histolytica: characterization of a pore-forming protein (PFP).

Authors:  J D Young; Z A Cohn
Journal:  J Cell Biochem       Date:  1985       Impact factor: 4.429

10.  Localization and molecular modelling of the membrane-inserted domain of the ninth component of human complement and perforin.

Authors:  M C Peitsch; P Amiguet; R Guy; J Brunner; J V Maizel; J Tschopp
Journal:  Mol Immunol       Date:  1990-07       Impact factor: 4.407

View more
  19 in total

1.  Down regulation of Entamoeba histolytica virulence by monoxenic cultivation with Escherichia coli O55 is related to a decrease in expression of the light (35-kilodalton) subunit of the Gal/GalNAc lectin.

Authors:  F Padilla-Vaca; S Ankri; R Bracha; L A Koole; D Mirelman
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  Amoebapores and NK-lysin, members of a class of structurally distinct antimicrobial and cytolytic peptides from protozoa and mammals: a comparative functional analysis.

Authors:  Heike Bruhn; Beate Riekens; Otto Berninghausen; Matthias Leippe
Journal:  Biochem J       Date:  2003-11-01       Impact factor: 3.857

3.  The second cysteine protease inhibitor, EhICP2, has a different localization in trophozoites of Entamoeba histolytica than EhICP1.

Authors:  M Sarić; A Vahrmann; I Bruchhaus; T Bakker-Grunwald; H Scholze
Journal:  Parasitol Res       Date:  2006-06-27       Impact factor: 2.289

4.  Intestinal invasion by Entamoeba histolytica.

Authors:  Shahram Solaymani-Mohammadi; William A Petri
Journal:  Subcell Biochem       Date:  2008

5.  Cytolytic and antibacterial activity of synthetic peptides derived from amoebapore, the pore-forming peptide of Entamoeba histolytica.

Authors:  M Leippe; J Andrä; H J Müller-Eberhard
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

Review 6.  Adherence and cytotoxicity of Entamoeba histolytica or how lectins let parasites stick around.

Authors:  J J McCoy; B J Mann; W A Petri
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

7.  Contact-dependent transfer of the galactose-specific lectin of Entamoeba histolytica to the lateral surface of enterocytes in culture.

Authors:  A Leroy; G De Bruyne; M Mareel; C Nokkaew; G Bailey; H Nelis
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

Review 8.  Laboratory diagnosis of amebiasis.

Authors:  Mehmet Tanyuksel; William A Petri
Journal:  Clin Microbiol Rev       Date:  2003-10       Impact factor: 26.132

Review 9.  Saposins and their interaction with lipids.

Authors:  A M Vaccaro; R Salvioli; M Tatti; F Ciaffoni
Journal:  Neurochem Res       Date:  1999-02       Impact factor: 3.996

Review 10.  Host-pathogen interaction in amebiasis and progress in vaccine development.

Authors:  C D Huston; W A Petri
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-09       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.